Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Newer Targets
Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody…
Newer Targets
Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to…
Newer Targets
Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Approval
AstraZeneca’s Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
Phase III
First China-manufactured Trastuzumab Biosimilar HLX02 Global Phase III Trial Met Primary…
Phase II
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study…
Approval
BRUKINSA (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
AbbVie and Harpoon Expand Partnership with $510 Million Licensing Deal
Acquisitions
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
Deals
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
Commercial
Eli Lilly to Add 100 Employees Following $400 Million Manufacturing Investment
Home
Authors
Posts by Firstwordpharma News
Firstwordpharma News
1234 POSTS
0 COMMENTS
Phase III
First China-manufactured Trastuzumab Biosimilar HLX02 Global Phase III Trial Met Primary...
Firstwordpharma News
-
November 22, 2019
0
Approval
BRUKINSA (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available...
Firstwordpharma News
-
November 21, 2019
0
Neurology
Investigational Drug for People with Treatment-Resistant Epilepsy
Firstwordpharma News
-
November 21, 2019
0
Phase II
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study...
Firstwordpharma News
-
November 21, 2019
0
NDA
BioMarin Submits Marketing Authorization Application to European Medicines Agency for Valoctocogene...
Firstwordpharma News
-
November 21, 2019
0
1
2
3
...
247
Page 1 of 247
- Advertisement -
MOST POPULAR
Bausch + Lomb Reports More Than 9.2 Million Units Of Contact...
April 22, 2019
Kodiak Sciences Announces Upcoming Presentation of KSI-301 12-Week Phase 1a Study...
February 8, 2019
BioSpace Movers and Shakers: March 22
March 22, 2019
Gilead and Novo Nordisk Team up to Tackle NASH
April 12, 2019
Load more
HOT NEWS
Commercial
ArQule to Present at the 2019 RBC Capital Markets Global Healthcare...
Others
Scottish Medicines Consortium daratumumab (Darzalex)
Orphan-paediatric
Takeda to Highlight Advancements in Rare Lysosomal Storage Disorders at Global...
Commercial
Engage Therapeutics to Present at the Stifel 2019 Healthcare Conference
